Costs, control or just good clinical practice? The use of antipsychotic medications and formulary decision-making in large U.S. prisons and jails

Journal of Offender Rehabilitation

Volumn 45, Issue 1-2, 2007, Pages 189-206

  Veysey, Bonita M ^a   Stenius, Vanja ^b   Mazade, Noel ^b   Schacht, Lucille ^b  

^a RUTGERS UNIVERSITY   (United States)

^b NONE

Author keywords

Antipsychotic; Jail; Medications; Mental health; Prison; Psychiatry

Indexed keywords

EID: 42649145062     PISSN: 10509674     EISSN: 15408558     Source Type: Journal    
DOI: 10.1300/J076v45n01_13     Document Type: Article

References (22)

1. American Psychiatric Association (1989). Psychiatric Services in Jails and Prisons. Washington, DC, American Psychiatric Association.
2. American Psychiatric Association (2000). Psychiatric Services in Jails and Prisons, 2nd Edition. Washington, DC, American Psychiatric Association.
3. Beck, A.J. & Maruschak, L.M. (2001). Mental health treatment in state prisons, 2000. Bureau of Justice Statistics Special Report. Washington, DC, US Department of Justice.
4. Brown, C.S., Markowitz, J.S., Moore, T.R. & Parker, N.G. (1999). Atypical anti-psycholics part II: Adverse effects, drug interactions, and costs. The Annals of Pharmacotheraphy, 33, 210-17.
5. Cohen, F. & Dvoskin, J. (1992). Inmates with mental disorders: A guide to law and practice. Mental and Physical Disability Law Reporter, 16 339-346, 462-470.
6. Ditton, P.M. (1999). Mental health treatment of inmates and probationers. Bureau of Justice Statistics Special Report. Washington, DC, US Department of Justice.
7. Glick, I.D., Murray, S.R., Vasudevan, P., Marder, S.R. & Hu, R.J. (2001). Treatment with atypical antipsychotics: New indications and new populations. Journal of Psychiatric Research, 35, 187-91.
8. Harrison, P.M. & Beck, A.J. (2006). Prison and jail inmates at midyear, 2005. Bureau of Justice Statistics Bulletin (NCJ213133). Washington, DC, US Department of Justice.
9. James, D.J. & Glaze, L.E. (2006). Mental health problems of prison and jail inmates. Bureau of Justice Statistics Special Report (NCJ213600). Washington, DC, US Department of Justice.
10. Koro, C.E., Fedder, D.O., L'Italien, G.J., Weiss, S., Magder, L.S., Kreyenbuhl, J., Revicki, D & Buchanan, R. W. (2002). An assessment of the independent effects of Olanzapine and Risperidone exposure on the rish of hyperlipidemia in schizophrenic patients. Archives of General Psychiatry, 59, 1021-26.
11. Leslie, D.L. & Rosenheck, R.A. (2002). From conventional to atypical antipsychotics and back: Dynamic processes in the diffusion of new medications. American Journal of Psychiatry, 159(9), 1534-40.
12. Markowitz, J.S., Brown, C.S. & Moore, T.R. (1999). Atypical antipsychotics, part I: Pharmacology, pharmacokinetics, and efficacy. The Annals of Pharmacotherapy, 33, 73-85.
13. Mazade, N., Glover, R. & Hutchings, G. (2001). Environmental scan, 2000: Issues facing state mental health agencies. Administration of Policy in Mental Health, 27(4), 167-81.
14. Meltzer, H.Y. (2005). The metabolic consequences of long-term treatment with olanzapine, quetiapine and risperidone: Are there differences? http://journals.cambridge.org/action/
15. Steadman, H.J. & Veysey, B.M. (1997). Providing services for jail inmates with mental disorder. National Institute of Justice: Research in Brief. Washington, DC, US Department of Justice.
16. Teplin, L.A. (1990). The Prevalence of severe mental disorder among male urban jail detainess: Comparison with the Epidemiologic Cathment Area Program. American Journal of Public Health, 80(6), 663-669.
17. Tenlin, L. A (1994) Psychiatric and substance abuse disorder among male urban detainees. American Journal of Public Health, 84(2), 290-93.
18. US Department of Health and Human Services (1999). Mental Health: A Report of the Sergeon General-Executive Summary. Rockville, MD, US Department of Health and Human Services.
19. Veysey, B.M. & Bichler-Robertson, G. (2002). Prevalence estimates of psychiatric disorders in correctional settings. In Health Status of Soon-To-Be Released Inmates. Report to Congress, Vol. 2. Chicago, National Commission on Correctional Health Care.
20. Veysey, B.M., Steadman, H.J., Morrissey, J.P. & Johnsen, M. (1997). In search of the missing linkages: Continuity of care in US jails. Behavioral Sciences and the Law, 15, 383-397.
21. Wolff, N. & Veysey, B.M. (2001). Correctional health care in New Jersey jails: Briefing paper. New Brunswick, NJ, Institute for Health, Health Care Policy and Aging Research.
22. Worrel, J.A., Marken, P.A., Beckman, S.E. & Ruehter, V.L. (2000). Atypical antipsychotic agents: A critical review. American Journal of Systems Pharmacy, 57, 238-255.